0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editor's Correspondence | 
Masashi Akiyama, MD, PhD; Nobuko Inamoto, MD, PhD
Arch Intern Med. 1998;158(13):1469-1472. doi:.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Related JAMA Internal Medicine Topics
From The JAMA Network
JAMA Ophthalmology
Small Case Series  | 
Failure of Systemic Propranolol Therapy for Choroidal Hemangioma of Sturge-Weber Syndrome:  A Report of 2 Cases
Hatem Krema, MD, FRCSEd; Yacoub A. Yousef, MD; Priya Durairaj, MD; et al.
JAMA Dermatology
Research Letters  | 
Retrospective Review of Adverse Effects From Propranolol in Infants
Eun-Kyung M. Kwon, BA; Shawna Joachim, BA; Dawn H. Siegel, MD; et al.
JAMA Dermatology
Practice Gaps  | 
Propranolol to Treat Hemangiomas of Infancy:  Safety and Side Effect Recognition
Comment on “Retrospective Review of Adverse Effects from Propranolol in Infants”
Jonathan A. Dyer, MD
JAMA Dermatology
Observation  | 
Eruptive Cherry Hemangiomatosis Associated With Multicentric Castleman Disease:  A Case Report and Diagnostic Clue
David Fajgenbaum, MSc; Misha Rosenbach, MD; Frits van Rhee, MD, PhD; et al.